BIOS - BioScrip Inc. (BIOS) CEO Dan Greenleaf on Q4 2018 Results and BioScrip and Option Care Merger Transaction (Transcript)
BioScrip, Inc. (BIOS)
Q4 2018 Results and BioScrip, and Option Care Merger Transaction Conference Call
March 15, 2019 09:00 AM ET
Company Participants
Kathryn Stalmack - SVP and General Counsel
Dan Greenleaf - President and CEO
Steve Deitsch - SVP, CFO and Treasurer
John Rademacher - CEO, Option Care
Mike Shapiro - CFO, Option Care
Conference Call Participants
David MacDonald - SunTrust
Richard Close - Canaccord
Brooks O'Neil - Lake Street Capital Markets
Mike Petusky - Barrington Research
Kevin Ellich - Craig-Hallum
Presentation
Operator
Greetings, and welcome to the BioScrip and Option Care Merger Transaction